Market Cap

BridgeBio Pharma, Inc. Market Capitalization:

$4.82 Billion

USD as of July 1, 2024

business BridgeBio Pharma, Inc. Company Profile

BridgeBio Pharma, Inc. Main Stock Listing

NASDAQ: BBIO

Market Capitalization History of BridgeBio Pharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of BridgeBio Pharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $6.56 B 488.77%
Jan. 1, 2023 $1.11 B -19.96%
Jan. 1, 2022 $1.39 B -82.61%
Jan. 1, 2021 $8.00 B 64.57%
Jan. 1, 2020 $4.86 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

BridgeBio Pharma, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

BridgeBio Pharma, Inc. has the following listings and related stock indices.


Stock: NASDAQ: BBIO

Stock: FSX: 2CL

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.